Abstract:Background & aims: Although most hepatocellular carcinoma (HCC) cases are driven by hepatitis and cirrhosis, a subset of patients with chronic hepatitis B develop HCC in the absence of advanced liver disease, indicating the oncogenic potential of hepatitis B virus (HBV). We investigated the role of HBV transcripts and proteins on HCC development in the absence of inflammation in HBV-transgenic mice. Methods: HBV-transgenic mice replicating HBV and expressing all HBV proteins from a single integrated 1.3-fold HBV genome in the presence or absence of wild-type HBx (HBV1.3/HBVxfs) were analyzed. Flow cytometry, molecular, histological and in vitro analyses using human cell lines were performed. Hepatocyte-specific Stat3- and Socs3-knockout was analyzed in HBV1.3 mice. Results: Approximately 38% of HBV1.3 mice developed liver tumors. Protein expression patterns, histology, and mutational landscape analyses indicated that tumors resembled human HCC. HBV1.3 mice showed no signs of active hepatitis, except STAT3 activation, up to the time point of HCC development. HBV-RNAs covering HBx sequence, 3.5-kb HBV RNA and HBx-protein were detected in HCC tissue. Interestingly, HBVxfs mice expressing all HBV proteins except a C-terminally truncated HBx (without the ability to bind DNA damage binding protein 1) showed reduced signs of DNA damage response and had a significantly reduced HCC incidence. Importantly, intercrossing HBV1.3 mice with a hepatocyte-specific STAT3-knockout abrogated HCC development. Conclusions: Expression of HBV-proteins is sufficient to cause HCC in the absence of detectable inflammation. This indicates the oncogenic potential of HBV and in particular HBx. In our model, HBV-driven HCC was STAT3 dependent. Our study highlights the immediate oncogenic potential of HBV, challenging the idea of a benign highly replicative phase of HBV infection and indicating the necessity for an HBV 'cure'. Impact and implications: Although most HCC cases in patients with chronic HBV infection occur after a sequence of liver damage and fibrosis, a subset of patients develops HCC without any signs of advanced liver damage. We demonstrate that the expression of all viral transcripts in HBV-transgenic mice suffices to induce HCC development independent of inflammation and fibrosis. These data indicate the direct oncogenic effects of HBV and emphasize the idea of early antiviral treatment in the 'immune-tolerant' phase (HBeAg-positive chronic HBV infection).

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

Mechanisms of HBx Mediated Liver Cancer: Multiple Pathways and Opportunities

Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.

HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx

Plk1 And Hotair Accelerate Proteasomal Degradation Of Suz12 And Znf198 During Hepatitis B Virus-Induced Liver Carcinogenesis

HBV integrations reshaping genomic structures promote hepatocellular carcinoma

Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan

Effects of Hepatitis B Virus X Protein on the Development of Liver Cancer

Hepatitis B Virus X Protein Confers Resistance of Hepatoma Cells to Anoikis by Up-Regulating and Activating P21-Activated Kinase 1

Hepatitis B Virus Large Surface Antigen Promotes Tumorigenesis of Human Hepatocellular Carcinoma Cells through Activating Src / PI 3 K / Akt Pathway

Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review

The Effects of Hepatitis B Virus Integration into the Genomes of Hepatocellular Carcinoma Patients

Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma

The Hepatitis B Virus X Protein Promotes Pancreatic Cancer Through Modulation of the PI3K/AKT Signaling Pathway.

Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42

Hepatitis B Virus X Protein in the Proliferation of Hepatocellular Carcinoma Cells

Hepatitis B Virus X Induces Inflammation and Cancer in Mice Liver Through Dysregulation of Cytoskeletal Remodeling and Lipid Metabolism

Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms And Novel Therapeutic Interventions